Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05855343 · ClinicalTrials.gov registry record · NA
Exploratory Study of Switching From Combustible Cigarettes to the BIDI E-cigarette
A NA study, sponsored by Rose Research Center.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05855343 is a NA study that has completed, run by Rose Research Center. The registered enrollment target is 25 participants.
The verdict
NCT05855343, a NA study, has completed, sponsored by Rose Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The aim of this study is to shed light on the importance of nicotine pharmacokinetics in switching to a reduced-harm product by fully matching the nicotine pharmacokinetics of smokers' usual brands of cigarettes. The primary objective is to ascertain the degree of smoking reduction when smokers attempt to switch to an e-cigarette that matches peak nicotine concentrations of a cigarette.
Interventions
- OTHER BIDI Stick e-cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-02-14 |
| Est. Completion | 2023-12-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05855343
The ClinicalTrials.gov registry entry for NCT05855343 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rose Research Center, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BIDI Stick e-cigarette is the first listed.
NCT05855343 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05855343 about?
NCT05855343 is a clinical study titled "Exploratory Study of Switching From Combustible Cigarettes to the BIDI E-cigarette". The aim of this study is to shed light on the importance of nicotine pharmacokinetics in switching to a reduced-harm product by fully matching the nicotine pharmacokinetics of smokers' usual brands of cigarettes. The primary objective is to ascertain the degree of smoking reduction when smokers att...
What is the current status of trial NCT05855343?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2023-02-14. Estimated completion is 2023-12-05.
What interventions are being tested in trial NCT05855343?
The interventions under investigation include: BIDI Stick e-cigarette (OTHER).
Who is sponsoring clinical trial NCT05855343?
This trial is sponsored by Rose Research Center, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.